Advertisement

---

ACTINIUM PHARMACEUTICALS, INC.

Actinium Pharmaceuticals, Inc. Receives $3.5m from Exercise of Warrants

[2013-06-07] - Actinium Pharmaceuticals receives US $3,457,087 in proceeds from the exercise of 2,095,204 A-warrants


Actinium Pharmaceuticals' Acute Myeloid Leukemia Clinical Data to be Presented Today at 8th International Symposium on Targeted Alpha Therapy Conference

[2013-06-05] - Targeted Alpha Therapy gains traction with three ongoing clinical alpha trials to be presented at the TAT Symposium in Oak Ridge, TN June 4 - 6, 2013


Actinium Pharmaceuticals, Inc. Receives Notice of Patent Allowance for a Key Application

[2013-05-13] - Actinium Pharmaceuticals allowed key claims in a cornerstone patent application for treatment of metastatic solid cancers with alpha emitting isotopes


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers